Eye surgery with steroid implant for membrane-related swelling
Part of Eyes & vision clinical trials.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You have a specific type of membrane on the retina (stage 3 or 4), seen on an eye scan
- The central part of your retina is swollen (thicker than 300 micrometers)
- Fluid is present in the central one millimeter of the retina
- The length of your eyeball (axial length) is less than 25.00 mm
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special intraocular lens (IOL) implanted during cataract surgery in people who also have epiretinal membrane (ERM), a thin layer of scar-like tissue on the retina. The goal is to see if this lens works well and safely for their eyes.
This trial tests a minimally invasive surgery for people with an epiretinal membrane, a thin layer of scar tissue on the retina that can blur or distort vision. The goal is to see if a smaller, less invasive approach is safe and effective.
This study checks how the retina changes after surgery to remove a wrinkled layer (epiretinal membrane). It's for people who already have had cataract surgery and are having the membrane removed because their vision is warped or blurry.
This study compares two surgical approaches for treating an idiopathic epiretinal membrane (a thin layer of scar tissue on the retina). It aims to see whether peeling the inner layer of the retina during surgery leads to better vision and fewer visual distortions.
This study tests whether a steroid medication can help reduce swelling in the back of the eye caused by diabetic macular edema, a complication of type 2 diabetes. If you qualify, you may receive this treatment to potentially improve your vision.
This trial tests whether combining a steroid implant (dexamethasone) with an anti-VEGF injection (aflibercept) works better than the injection alone for people with diabetic macular edema who haven't been treated yet. It aims to improve vision and reduce retinal swelling.
Hear when a new Epiretinal Membrane trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.